Skip to main content

Table 3 Perception of Episil®

From: Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study

 

Time after Episil® treatment (min.)

Baseline

5

30

60

120

Conversational difficulties

None—barely any

2 (20%)

5 (50%)

A little troublesome

6 (60%)

5 (50%)

Very troublesome

2 (20%)

0 (0%)

Eating difficulties

None—barely any

1 (10%)

5 (50%)

A little troublesome

5 (50%)

3 (30%)

Very troublesome

4 (40%)

2 (20%)

Ease of use of Episil®

Easy to use

7 (70%)

A little difficult to use

3 (30%)

Difficult to use

0 (0%)

Feeling and comfort in the mouth when Episil® is used

Good

2 (20%)

Ordinary

8 (80%)

Bad

0 (0%)

Changes in taste

None—barely any

6 (60%)

10 (100%)

9 (90%)

8 (80%)

A little troublesome

4 (40%)

0 (0%)

1 (10%)

2 (20%)

Very troublesome

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Stimulation of the mucous membrane

None—barely any

8 (80%)

9 (90%)

10 (100%)

9 (90%)

A little troublesome

2 (20%)

1 (10%)

0 (0%)

1 (10%)

Very troublesome

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Uncomfortable feeling

None—barely any

6 (60%)

8 (80%)

8 (80%)

9 (90%)

A little troublesome

3 (30%)

2 (20%)

2 (20%)

1 (10%)

Very troublesome

1 (10%)

0 (0%)

0 (0%)

0 (0%)

Acceptance and willingness to continue using Episil®

Want to keep using after this study

10 (100%)

10 (100%)

Don't want to use it anymore

0 (0%)

0 (0%)

  1. —: not tested